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Umbrella Sampling with PyBrella
Drug Discovery Steered Molecular Dynamics
Results and Analysis
Investigate use of other force constants and begin 
to develop a general method to determine force 
constants for each compound 
Test even larger collections of shorter runs instead 
of longer runs to improve speed and reduce error 
Expand to more compounds in the CSAR dataset 
Apply constraints on 
backbone to ensure that  
the compound exits 
 instead of bending  
the protein 
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So far, the link between actual efficacy and 
predicted free energy by PyBrella is insufficient 
since more data are necessary to confirm a 
correlation, though there is an expected trend. 
There are still large sources of error, for example 
in bias inherent in the SMD trajectory or distortion 
of the protein or drug structure. 
There is a surprisingly large reliance on the choice 
for the umbrella sampling force constant, 
suggesting odd behavior by WHAM since the 
PMF should ideally be independent of the force 
constant. 
The availability of more data in the longer runs is 
not necessarily better, since several compounds 
received uncharacteristic PMFs, but this 
determination is still inconclusive.
Conclusions
Modern drug discovery is a tedious process that is 
often limited by the expense and time of 
screening a target.   
Computational drug discovery provides an 
alternative method for generating hits to a target, 
by allowing: 
rapid screening, since computational 
technology and speed is still advancing; 
enormous numbers of compounds, by 
searching huge databases and using 
combinatorial chemistry for new molecules; 
and less effort and cost, by requiring less 
purchase of compounds and equipment.
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We used the technique of umbrella sampling, which: 
uses snapshots throughout the SMD trajectory as 
starting points for new simulations; 
requires local force restraints, to weakly hold the 
compound in place, and coverage of all distances; 
and is slower if implemented in a naïve fashion. 
To implement the method, we developed the program 
PyBrella, which extracts frames from SMD output, 
assigns constraints, controls simulation, then 
dynamically adds new runs so that all distances receive 
sampling to a minimum threshold, avoiding 
extraneous sampling. Then, it compares the first 80% 
to the last 20% of each run to determine convergence, 
and extends runs that have not converged.
Computational analysis usually consists of: 
spacial and electrostatic docking and matching 
of a potential compound; 
brief scoring and ranking of a compound's 
predicted efficacy; 
and in-depth evaluation of individual molecules 
deemed of sufficient quality. 
This last step is particularly resource and time-
intensive, making it often the limiting factor in 
drug screening. 
We seek to develop an effective and economical 
method to reliably correlate the actual rate of 
dissociation with a calculated trajectory of system 
energy, or potential of mean force (PMF). 
Choosing to avoid simple single-point calculations 
allows us to consider the full protein-water system 
and increase overall prediction accuracy. 
The study uses the dataset CSAR2012, which 
includes numerous test protein targets and 
associated known active/inactive compounds.
Molecular dynamics (MD) is the simulation of molecular motion that accounts for positions and trajectories. 
We used the MD package AMBER12 to simulate the removal of molecules from proteins by steered molecular 
dynamics (SMD): 
Proteins from the CSAR dataset were prepared with various ligands encapsulated in a periodic 20 Å water box, 
then were allowed to minimize and equilibrate for 1 nanosecond of simulation time. 
A pair of atoms was selected from the protein and the ligand in preparation for applying a pushing force to  
ensure a free exit path for the ligand.  
Constraints were added to the protein backbone to disallow distortion, and a simulated force was applied on the 
protein and ligand until they were 20 Å apart, allowing the ligand to escape into free solution.
Images of the simulation process, from the starting water box to the final exit of the molecule
Two main parameters have been under investigation: 
the usage of longer runs (10 ns) or collections of shorter runs (1 ns) for every distance position; 
and the choice of force constant for the umbrella sampling restraint, from a rigid k=50 to a loose k=5. 
Analysis is shown for a limited set of CSAR. Generally, long runs produce unsatisfactorily flat and uninformative PMF curves. Shorter 
runs yielded higher PMFs and more appropriate energy curves. Likewise, the smaller force constant k=5 showed drastically improved 
results over k=50, with much higher PMFs. Since CS245, CS260, and CS262 all have high actual affinities, a higher PMF is expected.
The correlation between the measured Kd and the 
predicted free energy is the determinant of success, and 
tentatively there is an expected correlation, using the 
short runs with k=5. 
A lower dissociation constant, corresponding to a 
stronger attraction, does indeed cause a higher PyBrella 
PMF across four compounds.
Finally, we use the Weighted Histogram Analysis 
Method (WHAM) to recover the PMF of the reaction.
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